Health Care Sector Update for 07/05/2019: TYME, CYAD, GRFS, JNJ, PFE, ABT, MRK, AMGN
Top Health Care Stocks:
Health care majors were mostly flat pre-market Friday.
Stocks moving on news include:
(+) Tyme Technologies ( TYME ), which was surging more than 30% after the emerging biotechnology company said its multi-center open-label mid-stage TYME-88-Panc study evaluating SM-88 as an oral monotherapy in patients with advanced pancreatic cancer continued to demonstrate “encouraging” results and a well-tolerated safety profile.
(=) Celyad SA ( CYAD ) was flat after saying interim data of a phase 1 alloSHRINK trial of CYAD-101 in metastatic colorectal cancer did not show any evidence of graft versus host disease, and interim results from its phase 1 SHRINK trial of CYAD-01, which showed that the drug was generally well tolerated.
(+) Grifols ( GRFS ) was rallying by almost 3% as the FDA approved Xembify, the company’s new 20% subcutaneous immunoglobulin, to treat primary immunodeficiencies.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.